The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.
March 12th 2025
Cabotegravir was found to prevent HIV acquisition as a monotherapy pre-exposure prophylaxis (PrEP) and to treat HIV as a combination antiretroviral therapy (ART) in its long-acting injectable form.
Dr Milena Murray: Affordability Conversations Should Begin at the Prescriber’s Office
November 10th 2020What is feasible for one person may be unaffordable for another, said Milena Murray, PharmD, MSc, BCIDP, AAHIVP, associate professor, Midwestern University Chicago College of Pharmacy, who practices at the Northwestern Medicine Infectious Disease Center.
Watch
Dr Milena Murray on Ensuring Ongoing Patient Interactions During the COVID-19 Pandemic
November 5th 2020Partnering with pharmacists ensures prescription availability for patients with HIV during the coronavirus disease 2019 (COVID-19), noted Milena Murray, PharmD, MSc, BCIDP, AAHIVP, of Midwestern University College of Pharmacy.
Watch
Dr Milena Murray on the Importance of Using People-First Language With Patients Living With HIV
October 30th 2020The patients must always come first, emphasized Milena Murray, PharmD, MSc, BCIDP, AAHIVP, associate professor at Midwestern University College of Pharmacy, who practices at the Northwestern Medicine Infectious Disease Center in Chicago.
Watch
Perinatal Exposure to HIV Requires Specialized, Coordinated Care
October 19th 2020Pediatricians and pediatric HIV specialists need to coordinate their care plans for infants born with potential perinatal exposure to the virus, according to a new report from the American Academy of Pediatrics.
Read More
What Factors Are Predictive of Lower ART Adherence Among Hispanic, Latino MSM?
October 13th 2020Younger age, poverty, recent drug use, depression, and unmet need for ancillary services were linked to lowered antiretroviral therapy (ART) adherence among HIV-positive Hispanic and Latino men who have sex with men (MSM).
Read More
PrEP Costs Must Come Down for Uptake to Increase, Study Says
September 26th 2020Over a 4-year study period, the price for 30 tablets of preexposure prophylaxis (PrEP) medication increased more than 20%, potentially keeping the medication out of the hands of those most at risk for potentially contracting HIV.
Read More
Drug Resistance Mutations Increasingly Showing Up in Germany Among HIV-Positive Individuals
September 22nd 2020Despite the known benefits of antiretroviral therapy, the treatment may prove more difficult to use among clusters of patients with HIV exhibiting resistance to certain drug classes.
Read More
Remote HIV Testing, Phone Delivery of Results Has Potential Despite Drawbacks
September 19th 2020Because men who have sex with men continue to represent a disproportionate number of annual HIV diagnoses each year, a recent study investigated the utility of remote testing and phone delivery of test results among the patient group.
Read More
Dr Anthony Fauci Speaks to the Likelihood of Vaccines for HIV and COVID-19
September 10th 2020A vaccine for coronavirus disease 2019 (COVID-19) is aspirationally possible by the end of the year and the beginning of 2021, noted Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases.
Watch
How Were HIV Care Services in South Carolina Interrupted by the COVID-19 Pandemic?
September 1st 2020Results from a recent study in the state show how its HIV service care continuum was affected by the coronavirus disease 2019 pandemic (COVID-19), namely that more than a quarter of HIV clinics had to close completely.
Read More
Short-Term PrEP May Be Effective Alternative Method of HIV Prevention Among MSM
August 19th 2020Gay, bisexual, and other men who have sex with other men (MSM) during episodes of high-risk behavior could benefit from short-term use of preexposure prophylaxis (PrEP) to lessen their chances of contracting HIV, a new study reports.
Read More
Saliva May Be a Reliable Alternative to Blood for HIV Antibody Testing
August 13th 2020HIV-specific antibodies of 3 immunoglobulin isotypes are readily found in human saliva, providing a potential second reliable method of detecting the virus that may be used as a painless alternative to a blood draw.
Read More
HIV Education, Prevention Efforts See Lukewarm Results in Dhaka, Bangladesh
August 7th 2020A 3-year endeavor to scale up HIV prevention and education efforts among men who have sex with men in Dhaka, Bangladesh, showed only modest gains in the country where intercourse with a same-sex partner could mean a lifetime jail sentence.
Read More
Immunosuppression to Blame for Oral Microbiota Change in Children With HIV
August 5th 2020Bacterial changes in the oral cavity from immunosuppression, not HIV itself, are more likely to blame for the greater incidence of oral caries in children 6 months to 6 years, reports a study from the Department of Oral Biology at the Rutgers University School of Dental Medicine.
Read More
NIH Deems Kidney Transplantation Safe Between HIV-Positive Donors and Recipients
July 29th 2020HIV-positive individuals with end-stage kidney disease may now have a larger pool of kidneys available to them, with recent study results from the National Institutes of Health (NIH) showing that kidneys from HIV-positive deceased donors can be used in addition to those from HIV-negative donors.
Read More